C6ORF89 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.51619827803984E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.62379999999207E-06 |
Normal-vs-Stage2 |
3.15420000118749E-08 |
Normal-vs-Stage3 |
3.77475828372553E-14 |
Normal-vs-Stage4 |
1.62914126633495E-12 |
Stage1-vs-Stage2 |
1.587900E-02 |
Stage1-vs-Stage3 |
1.51532000000065E-05 |
Stage1-vs-Stage4 |
1.97420000014326E-07 |
Stage2-vs-Stage3 |
5.382400E-01 |
Stage2-vs-Stage4 |
1.539170E-01 |
Stage3-vs-Stage4 |
2.726000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.09400266623538E-11 |
Normal-vs-AfricanAmerican |
1.53072999999893E-05 |
Normal-vs-Asian |
1.353200E-01 |
Caucasian-vs-AfricanAmerican |
7.635400E-01 |
Caucasian-vs-Asian |
3.408400E-01 |
AfricanAmerican-vs-Asian |
4.893000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.11426489835776E-12 |
Normal-vs-Female |
1.6772000011045E-08 |
Male-vs-Female |
3.598400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.023800E-04 |
Normal-vs-Age(41-60Yrs) |
1.27910000369269E-08 |
Normal-vs-Age(61-80Yrs) |
6.84008405471559E-12 |
Normal-vs-Age(81-100Yrs) |
2.31449999998912E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.550000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.602600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.828400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.919390E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.780450E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.725800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.965200E-01 |
Normal-vs-Grade 2 |
2.02260000004006E-06 |
Normal-vs-Grade 3 |
1.92368343476801E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
6.177900E-03 |
Grade 1-vs-Grade 3 |
3.61170000000577E-05 |
Grade 1-vs-Grade 4 |
8.58430004857524E-09 |
Grade 2-vs-Grade 3 |
3.044600E-04 |
Grade 2-vs-Grade 4 |
3.23719995254379E-09 |
Grade 3-vs-Grade 4 |
4.424400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.22679999999364E-05 |
Normal-vs-ccB subtype |
1.96970217913872E-11 |
ccA subtype-vs-ccB subtype |
4.50360000003869E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.72520039657343E-10 |
Normal-vs-N1 |
1.015930E-04 |
N0-vs-N1 |
3.184400E-01 |
|
|